Scarica l'app Stockscreener
277.29
1.89%
-5.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$282.64
Aprire:
$277.04
Volume 24 ore:
4.37M
Relative Volume:
1.42
Capitalizzazione di mercato:
$157.90B
Reddito:
$33.42B
Utile/perdita netta:
$4.09B
Rapporto P/E:
36.73
EPS:
7.55
Flusso di cassa netto:
$10.39B
1 W Prestazione:
-1.46%
1M Prestazione:
-12.57%
6M Prestazione:
-13.71%
1 anno Prestazione:
+5.01%
Intervallo 1D:
$268.50
$278.68
Intervallo di 1 settimana:
$268.50
$296.17
Portata 52W:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
277.29 | 157.90B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
839.96 | 677.40B | 45.04B | 10.59B | 414.30M | 11.71 |
|
JNJ
Johnson Johnson
|
157.47 | 371.98B | 89.33B | 21.81B | 18.06B | 8.99 |
|
ABBV
Abbvie Inc
|
172.99 | 316.82B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
58.08 | 293.24B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
110.86 | 216.19B | 51.72B | 11.94B | 13.81B | 5.88 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Follow the Data - Amgen
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Jaffetilchin Investment Partners LLC - MarketBeat
Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025 - Insider Monkey
Targeted Therapy Market Future Business Opportunities 2025-2032 | Amgen Inc., GlaxoSmithKline plc, Sanofi - openPR.com
Amgen: The Biotech That Knows How To Make Money (NASDAQ:AMGN) - Seeking Alpha
Integrity Wealth Advisors Inc. Takes $977,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Rossby Financial LCC Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Guggenheim Capital LLC Sells 8,356 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
CreativeOne Wealth LLC Raises Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by LSV Asset Management - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Kennedy Capital Management LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
NVIDIA Corp., Amgen share losses contribute to Dow's 886-point drop - MSN
NVIDIA Corp., Amgen share losses lead Dow's 589-point fall - MSN
Biosimilars Market Set to Witness Significant Growth - openPR.com
NVIDIA Corp., Amgen share losses lead Dow's 200-point fall - MSN
Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents - BioPharma Dive
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Mariner LLC - MarketBeat
Belpointe Asset Management LLC Purchases 1,638 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fund Update: FERGUSON WELLMAN CAPITAL MANAGEMENT, INC added 170,577 shares of AMGEN ($AMGN) to their portfolio - Nasdaq
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Trustmark National Bank Trust Department - MarketBeat
Advisors Capital Management LLC Purchases 3,427 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Herceptin Biosimilar Market Overall Study Report 2025-2032 | - openPR.com
Qtron Investments LLC Sells 876 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Philadelphia Trust Co. Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Neuberger Berman Group LLC - MarketBeat
Alston & Bird Allege Big Pharma Company Amgen Monopolized US Arthritis Drug Market - Law.com
HHS Rejects Amgen, Lilly Fight of Clinics in Drug Discount Plan - Bloomberg Law News
Goldman Sachs Adjusts Price Target on Amgen to $400 From $408, Maintains Buy Rating - MarketScreener
Lobbying Update: $60,000 of AMGEN INC lobbying was just disclosed - Nasdaq
Savvy Advisors Inc. Buys 2,087 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bragg Financial Advisors Inc Decreases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Stamos Capital Partners L.P. Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Townsquare Capital LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by RE Dickinson Investment Advisors LLC - MarketBeat
Sagespring Wealth Partners LLC Invests $3.78 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
EPO and UPC disagree on validity of Amgen’s patent for cholesterol drug - JUVE Patent
Renaissance Technologies LLC Invests $18 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Legacy Financial Advisors Inc. - MarketBeat
Zuckerman Investment Group LLC Invests $521,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argent Trust Co Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Azimuth Capital Investment Management LLC Cuts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Clinical Trial Optimization - Amgen
Human & Disease Biology - Amgen
AI in Research & Development - Amgen
Novel Targets & Modalities - Amgen
Treasurer of the State of North Carolina Buys 1,291 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
FDA Approval of Amgen's UPLIZNA for IgG4-related Disease Opens New Market Opportunity in Rare Autoimmune Segment | DelveInsight - Yahoo Finance
Sandoz Sues Amgen Over Alleged Monopoly Tactics - USA Herald
Sandoz Sues Amgen Over Enbrel Biosimilar - Law360
Sector Update: Health Care Stocks Rise Monday Afternoon - MarketScreener
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):